Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Visual Agnosia01:12

Visual Agnosia

892
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
892
Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Good Visual Recovery in Patients With Spontaneously Resolved Acute CSCR - MICRoN Report Number Thirteen.

American journal of ophthalmology·2026
Same author

Corrigendum to Peripapillary Retinoschisis: The Expanded Spectrum and New Insights From Multimodal Imaging. Am J Ophthalmol. 2026;282:26-40.

American journal of ophthalmology·2026
Same author

"Getting to diagnosis was an absolute nightmare": survey insights about the lived experience of spinal CSF leak in Australia and Aotearoa New Zealand.

Journal of neurology·2026
Same author

Unilateral Retinal Pigment Epithelium Dysgenesis-The Expanded Spectrum and New Insights From Multimodal Imaging.

American journal of ophthalmology·2026
Same author

Clinical Characteristics and Outcomes in Central Serous Chorioretinopathy With Subretinal Hyper-Reflective Material: MICRoN Report 6.

American journal of ophthalmology·2026
Same author

Developing age-related macular degeneration recommendations for clinical optometrists via a modified Delphi study.

Clinical & experimental optometry·2026
Same journal

Biopsy of Iris and Anterior Chamber Tumours: Fine Needle, Minimally Invasive and Excision Techniques - Review.

Clinical & experimental ophthalmology·2026
Same journal

Ray-Tracing-Based Intraocular Lens Power Calculation in Combined Cataract Surgery and Descemet Membrane Endothelial Keratoplasty.

Clinical & experimental ophthalmology·2026
Same journal

Comparative Efficacy of Two Defocus Soft Contact Lenses on Axial Length and Choroid in High Myopic Adolescents: Comment.

Clinical & experimental ophthalmology·2026
Same journal

Lessons Learnt From 25 Years of Endophthalmitis: Causes, Microbiology and Visual Outcome Trends.

Clinical & experimental ophthalmology·2026
Same journal

Aqueous Humour Outflow Assessment Using Imaging-Based Techniques in Angle-Based Minimally Invasive Glaucoma Surgery (MIGS): A Systematic Review.

Clinical & experimental ophthalmology·2026
Same journal

Interpreting Hyperreflective Foci in Age-Related Macular Degeneration: A Critical Review of Cell Origins, Evolving Terminology and Clinical Utility.

Clinical & experimental ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

1.1K

Visual Function Assessment in Geographic Atrophy: A Review.

Ye Li1, Lauren N Ayton2,3,4, Adrian T Fung5,6,7,8

  • 1Department of Ophthalmology, Royal Brisbane and Women's Hospital, Brisbane, Australia.

Clinical & Experimental Ophthalmology
|December 12, 2025
PubMed
Summary
This summary is machine-generated.

Geographic atrophy (GA) significantly impacts vision and quality of life. This review highlights the need for robust visual function tests, beyond structural imaging like fundus autofluorescence (FAF), to accurately assess GA progression and treatment efficacy.

Keywords:
functional visiongeographic atrophyvision function

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.5K
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

1.1K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.5K
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.3K

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Clinical Trials

Background:

  • Geographic atrophy (GA) leads to severe vision impairment and reduced quality of life.
  • Fundus autofluorescence (FAF) is standard for GA assessment but is a surrogate for vision loss.
  • Current visual function tests like best-corrected visual acuity (BCVA) are inadequate for tracking GA progression.

Purpose of the Study:

  • To review the association between FAF and visual function tests in GA patients.
  • To emphasize the importance of functional vision assessment in GA clinical trials.
  • To guide the selection of appropriate endpoints for evaluating GA treatments.

Main Methods:

  • Literature review focusing on the correlation between FAF imaging and various visual function tests.
  • Analysis of existing data on tests including low luminance visual acuity (LLVA), reading speed, and microperimetry.
  • Examination of patient-reported outcomes for functional vision assessment.

Main Results:

  • FAF is a structural marker, but visual function tests provide a more direct measure of vision loss in GA.
  • Standard BCVA is often confounded by GA's late-stage foveal involvement and slow progression.
  • A variety of functional vision tests show promise for better GA assessment.

Conclusions:

  • Future GA clinical trials require a comprehensive suite of visual function endpoints.
  • Focusing on rapidly progressing GA lesion phenotypes will enhance the detection of treatment benefits.
  • Accurate functional vision assessment is crucial for regulatory approval of new GA therapies.